Skip to main content
. 2021 Dec 13;19(12):2233–2249. doi: 10.2174/1570159X19666210517115706

Table 2.

Pharmacological treatments of RLS in PD patients.

Recommended Dose Benefits Side Effects
Levodopa 200-300mg [80] improve nighttime RLS symptoms; improve overnight motor and non-motor symptoms; reduce pain aggravate RLS; symptoms rebound in the morning; dyskinesia
Dopaminergic agonists
Pramipexole 0.375- 4.5 mg [74] improve nighttime RLS symptoms; improve overnight motor and non-motor symptoms; reduce pain visual hallucinations; daytime somnolence; sudden sleep attack; fatigue; nausea; ICD; orthostatic hypotension; edema
Ropinirole 0.25-4.0mg [81] improve nighttime RLS symptoms; improve overnight motor and non-motor symptoms aggravate RLS; dyskinesia; headache; dizziness; daytime somnolence; nausea; leg edema
Rotigotine 2-16mg [82] improve nighttime RLS symptoms; improve overnight and early morning motor performance; reduce nocturia local site reactions; dyskinesias; headache; dizziness; daytime somnolence; fatigue; nausea
α2δ ligands
Gabapentin 800 mg
(100 mg for patients >65 years initial daily dose)
(200 mg for patients with uraemia) [56, 83]
improve nighttime RLS symptoms; reduce pain dizziness; daytime somnolence; peripheral edema
Pregabalin 150-450 mg
(50 mg for patients >65 years initial daily dose) [56, 83]
improve nighttime RLS symptoms;improve subjective nighttime sleep; reduce pain dizziness; daytime somnolence; headache; fatigue
Gabapentin enacarbil 600-1200 mg
(300 mg for patients >65 years initial daily dose) [56, 83]
improve nighttime RLS symptoms; reduce pain daytime somnolence; headache; fatigue
Others
Apomorphine 18- 48 mg [84] improve nighttime RLS symptoms; reduce pain and spasm rebound morning stiffness; subcutaneous nodules